|
References | DXA scanner manufacturer | BMD sites | CVa of BMD measurements | Baseline BMD (mean ± SD) | Posttreatment BMD (mean ± SD) | BMD scales | Serum IGF1 changes |
|
Hansen et al., 1996 [13] | Hologic Inc. | Spine FN TB | 0.6% 1.4% 1.6% | |
| g/cm2 | Increased |
|
Johannsson et al., 1996 [14] | GE-Lunar | Spine FN TB | 0.5% 1.6% 0.4% | |
| g/cm2 | Increased from to 3μg/L |
|
Rodríguez-Arnao et al., 1998 [15] | Hologic Inc. | Spine FN TB | 1.0% 1.8% NAb | |
| g/cm2 | Increased significantly with 31% of the total patients showing IGF1 levels above the age-corrected limit of normal |
|
Cuneo et al., 1998 [16] | GE-Lunar | TB | <3.8% | | | g/cm2 | Increased from 100 to μg/L |
|
Biller et al., 2000 [17] | Hologic Inc. | Spine FN TB | NA NA NA |
|
| g/cm2 | NA |
|
Koranyi et al., 2001 (1) [18] | GE-Lunar | FN TB | NA NA |
|
| g/cm2 | Increased from to μg/L |
|
Koranyi et al., 2001 (2) [18]
| GE-Lunar | FN TB | NA NA |
|
| g/cm2 | Increased from to μg/L |
|
Lanzi et al., 2003 [19] | Hologic Inc. | Spine FN | 0.5% NA |
|
| t-score | Increased from to μg/L |
|
Underwood et al., 2003 (1) [20] | GE-Lunar | Spine | NA | | | z-score | IGF1 SDS increased from to |
|
Underwood et al., 2003 (2) [20] | GE-Lunar | Spine | NA | | | z-score | IGF1 SDS increased from to |
|
Hubina et al., 2004 (1) [21] | Hologic Inc. | Spine FN | 0.35% NA |
|
| t-score | IGF1 SDS increased from to |
|
Hubina et al., 2004 (2) [21] | Hologic Inc. | Spine FN | 0.35% NA |
|
| t-score | IGF1 SDS increased from to |
|
Bravenboer et al., 2005 [22] | Norland | Spine FN | 2.4% 2.3% |
|
| g/cm2 | Increased from to nM |
|
Arwert et al., 2005 [23] | Hologic Inc. | Spine FN | NA 2.1% |
|
| g/cm2 | Increased from to nM |
|
Boguszewski et al., 2005 [24] | GE-Lunar | Spine FN | 1.2% 1.5% |
|
| g/cm2 | Increased from to μg/L |
|
Benedini et al., 2006 [25] | Hologic Inc. | Spine | NA | | | g/cm2 | Increased from to μg/L |
|
Snyder et al., 2007 [26] | Hologic Inc. | Spine FN | 0.37–0.51% |
|
| g/cm2 | IGF1 SDS increased from to |
|
Gotherstrom et al., 2007 [27] | GE-Lunar | Spine FN TB | 0.5% 0.6% 0.4% |
|
| g/cm2 | Increased from to μg/L |
|
Rota et al., 2008 [28] | Hologic Inc. | Spine FN | 1.0% 1.5% |
|
| z-score | Increased in men and in women |
|
Fideleff et al., 2008 [10] | GE-Lunar | Spine FN TB | NA NA NA |
|
| z-score | IGF1 SDS increased from to |
|
Conway et al., 2009 [29] | Hologic Inc. | Spine TB | NA NA |
|
| g/cm2 | Increased from to μg/L |
|
Van den Heijkant et al., 2011 [11] | Hologic Inc. | Spine FN TB | NA NA NA |
|
| g/cm2 | NA |
|
Elbornsson et al., 2012 [30] | GE-Lunar | Spine FN TB | <1.5% |
|
| g/cm2 | Increased from to μg/L |
|